Annual FCF
-$10.30 M
+$2.94 M+22.22%
31 December 2023
Summary:
Qualigen Therapeutics annual free cash flow is currently -$10.30 million, with the most recent change of +$2.94 million (+22.22%) on 31 December 2023. During the last 3 years, it has risen by +$4.57 million (+30.71%). QLGN annual FCF is now at all-time high.QLGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.80 M
-$325.40 K-22.07%
30 September 2024
Summary:
Qualigen Therapeutics quarterly free cash flow is currently -$1.80 million, with the most recent change of -$325.40 thousand (-22.07%) on 30 September 2024. Over the past year, it has increased by +$3.87 million (+68.26%). QLGN quarterly FCF is now -293.60% below its all-time high of $929.70 thousand, reached on 30 September 2023.QLGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$9.73 M
-$2.73 M-38.99%
30 September 2024
Summary:
Qualigen Therapeutics TTM free cash flow is currently -$9.73 million, with the most recent change of -$2.73 million (-38.99%) on 30 September 2024. Over the past year, it has increased by +$574.70 thousand (+5.58%). QLGN TTM FCF is now -11194.18% below its all-time high of $87.70 thousand, reached on 30 September 2019.QLGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +68.3% | +5.6% |
| 3 y3 years | +30.7% | +38.6% | +34.6% |
| 5 y5 years | - | -579.9% | -10000.0% |
QLGN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +30.7% | -293.6% | +68.3% | -41.6% | +41.6% |
| 5 y | 5 years | at high | +30.7% | -293.6% | +73.3% | <-9999.0% | +41.6% |
| alltime | all time | at high | +30.7% | -293.6% | +73.3% | <-9999.0% | +41.6% |
Qualigen Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.80 M(+22.1%) | -$9.73 M(+39.0%) |
| June 2024 | - | -$1.47 M(+88.2%) | -$7.00 M(-17.2%) |
| Mar 2024 | - | -$783.60 K(-86.2%) | -$8.45 M(-18.0%) |
| Dec 2023 | -$10.30 M(-22.2%) | -$5.67 M(-710.0%) | -$10.30 M(+50.0%) |
| Sept 2023 | - | $929.70 K(-131.7%) | -$6.87 M(-37.1%) |
| June 2023 | - | -$2.93 M(+11.2%) | -$10.92 M(-8.6%) |
| Mar 2023 | - | -$2.63 M(+17.7%) | -$11.95 M(-9.8%) |
| Dec 2022 | -$13.25 M | -$2.24 M(-28.2%) | -$13.25 M(-5.0%) |
| Sept 2022 | - | -$3.12 M(-21.3%) | -$13.94 M(+0.6%) |
| June 2022 | - | -$3.96 M(+0.7%) | -$13.86 M(-16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.93 M(+34.2%) | -$16.65 M(+12.0%) |
| Dec 2021 | -$14.87 M(+43.3%) | -$2.93 M(-3.7%) | -$14.87 M(+24.5%) |
| Sept 2021 | - | -$3.04 M(-54.9%) | -$11.94 M(-12.2%) |
| June 2021 | - | -$6.75 M(+213.9%) | -$13.60 M(+44.1%) |
| Mar 2021 | - | -$2.15 M(-54.3%) | -$9.44 M(+29.5%) |
| Dec 2020 | -$10.38 M | - | - |
| Sept 2020 | - | -$4.70 M(+81.8%) | -$7.29 M(+229.5%) |
| June 2020 | - | -$2.59 M(-789.8%) | -$2.21 M(-2622.7%) |
| Sept 2019 | - | $375.10 K(-230.5%) | $87.70 K(-130.5%) |
| June 2019 | - | -$287.40 K | -$287.40 K |
FAQ
- What is Qualigen Therapeutics annual free cash flow?
- What is the all time high annual FCF for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly FCF year-on-year change?
- What is Qualigen Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Qualigen Therapeutics?
- What is Qualigen Therapeutics TTM FCF year-on-year change?
What is Qualigen Therapeutics annual free cash flow?
The current annual FCF of QLGN is -$10.30 M
What is the all time high annual FCF for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual free cash flow is -$10.30 M
What is Qualigen Therapeutics quarterly free cash flow?
The current quarterly FCF of QLGN is -$1.80 M
What is the all time high quarterly FCF for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly free cash flow is $929.70 K
What is Qualigen Therapeutics quarterly FCF year-on-year change?
Over the past year, QLGN quarterly free cash flow has changed by +$3.87 M (+68.26%)
What is Qualigen Therapeutics TTM free cash flow?
The current TTM FCF of QLGN is -$9.73 M
What is the all time high TTM FCF for Qualigen Therapeutics?
Qualigen Therapeutics all-time high TTM free cash flow is $87.70 K
What is Qualigen Therapeutics TTM FCF year-on-year change?
Over the past year, QLGN TTM free cash flow has changed by +$574.70 K (+5.58%)